We are live on ! Find out more
ORTX

Orchard Therapeutics plc American Depositary Shares
ORTX

Delisted

ORTX was delisted on the 23rd of January, 2024.

Back to rankings

0 hedge funds and large institutions have $0 invested in Orchard Therapeutics plc American Depositary Shares in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 47 → 0 (-47)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less capital invested

Capital invested by funds: $122M → $0 (-$122M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 47

Holders
–
Holders Change
-47
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
47
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
DTC
Deep Track Capital
Connecticut
-$33.6M
2
BCM
Beryl Capital Management
California
-$25.7M
3
Federated Hermes
Federated Hermes
Pennsylvania
-$14.3M
4
LP
LMR Partners
United Kingdom
-$5.47M
5
Tudor Investment Corp
Tudor Investment Corp
Connecticut
-$4.93M
Name Holding Trade Value Shares
Change 		Change in
Stake
PCM
26
PenderFund Capital Management
British Columbia, Canada
– -$514K -23,580 Closed
GI
27
GAMCO Investors
Connecticut
– -$250K -15,188 Closed
FIA
28
FNY Investment Advisers
New York
– -$246K -15,000 Closed
GS
29
GTS Securities
New York
– -$247K -15,000 Closed
VA
30
Vident Advisory
Georgia
– -$185K -11,270 Closed
HM
31
Harvest Management
New York
– -$165K -10,000 Closed
WP
32
Woodline Partners
California
– -$165K -10,000 Closed
Morgan Stanley
33
Morgan Stanley
New York
– -$71.9K -4,372 Closed
EC
34
EntryPoint Capital
New York
– -$33.2K -2,020 Closed
RhumbLine Advisers
35
RhumbLine Advisers
Massachusetts
– -$21.7K -1,318 Closed
Group One Trading
36
Group One Trading
Illinois
– -$19.7K -1,197 Closed
Wells Fargo
37
Wells Fargo
California
– -$18.9K -1,150 Closed
Osaic Holdings
38
Osaic Holdings
Arizona
– -$9.24K -562 Closed
BCV
39
Banque Cantonale Vaudoise
Switzerland
– -$7K -400 Closed
UBS Group
40
UBS Group
Switzerland
– -$6.25K -380 Closed
Bank of America
41
Bank of America
North Carolina
– -$4.66K -283 Closed
Citigroup
42
Citigroup
New York
– -$1.81K -110 Closed
CWP
43
Concord Wealth Partners
Virginia
– -$1.65K -100 Closed
Carson Wealth (CWM LLC)
44
Carson Wealth (CWM LLC)
Nebraska
– -$1K -83 Closed
BHWM
45
Beaird Harris Wealth Management
Texas
– -$198 -12 Closed
MAWCM
46
Mine & Arao Wealth Creation & Management
California
– -$165 -10 Closed
CWM
47
Compass Wealth Management
Connecticut
– -$149 -9 Closed
1
2

ORTX Hedge Fund Activity: Q1 2024 in Review

0 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Orchard Therapeutics plc American Depositary Shares (ORTX) for Q1 2024, worth a combined $0 — down 100% from $122M a quarter earlier.

Sellers outnumbered buyers: 47 funds closed out of ORTX and 0 opened new positions — a net loss of 47 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Deep Track Capital, exiting entirely with an estimated $33.6M sold.

  • 0 institutional investors held Orchard Therapeutics plc American Depositary Shares (ORTX) as of Q1 2024, down from 47 in Q4 2023.
  • Funds reported $0 of Orchard Therapeutics plc American Depositary Shares stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Orchard Therapeutics plc American Depositary Shares positions in Q1 2024 and 47 closed out, a net change of -47 holders.
  • The largest Orchard Therapeutics plc American Depositary Shares seller in Q1 2024 was Deep Track Capital, an estimated $33.6M sold.

Based on aggregated 13F filings for Q1 2024.